Php196 - Development Strategies Promoting Pharmaceutical Industry to Improve Healthcare Management

Abstract

digital health solutions. Published MIBs outlined evidence from both real world observational studies and controlled trials. CONCLUSIONS: Although noncompulsory, the number of published MIBs is rising, suggesting an increasing focus on new innovations within the UK NHS. MIBs provide a forum for communicating the effectiveness, safety, costs and resource implications of medical technology solutions across a range of applications. Since MIBs do not include recommendations, more detailed guidance is needed to help manufacturers develop robust evidence-bases and assist stakeholders with decision-making regarding which are the most clinically-effective, resource-efficient and/or cost-effective options in comparison with standard care.